secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CIK:        0001979414
Form:       8-K
Filed at:   2025-12-05T23:59:59+00:00
Accession:  0001829126-25-009754
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeOnc raises $1M from Saad Naja; AI study shows ultrasound boosts NEO100 against brain tumors
--------------------------------------------------------------------------------

- Issued 111,732 shares at $8.95 to Saad Naja, raising gross proceeds of ~$1M for working capital.
- Preclinical collaboration with USC (bioRxiv) shows NEO100 combined with focused ultrasound enhances tumor killing in glioblastoma, medulloblastoma, meningioma, and metastases.
- AI-trained platform using 200+ molecular descriptors identified NEO100 as a leading sonosensitizer; 3D-bioprinted organoids validated results in days vs. weeks.
- Results support moving NEO100-plus-ultrasound into future clinical trials for multiple primary and metastatic brain tumors.
- CEO Heshmatpour says findings expand NEO100's commercial and clinical opportunity beyond current indications.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1979414/000182912625009754/0001829126-25-009754-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1979414/000182912625009754/neonctechnologies_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-009754

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer